Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Correvio Pharma Corp. CORV

Healthcare Drug Manufacturers - Major
Correvio Pharma Corp is specialty pharmaceutical company. It offers patients and healthcare providers therapeutic solutions for acute medical conditions to improve health and quality of life. Its products are Aggrastat, Esmocard, Brinavess, Xydalba, Zevtera/Mabelio, and others. It offers solutions on Acute Bacterial Skin and Skin Structure Infections, Acute Coronary Syndromes, Atrial... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:CORV)

Correvio Obtains Final Order for Plan of Arrangement

Canada NewsWire May 21, 2020

Correvio Announces Results from Annual General and Special Meeting of Securityholders

Canada NewsWire May 15, 2020

Leading Independent Proxy Advisory Firm Glass Lewis Recommends That Correvio Shareholders Vote for the Arrangement With ADVANZ PHARMA

Canada NewsWire May 6, 2020

Correvio Announces Postponement of Its First Quarter 2020 Financial Results Due to Impacts From COVID-19

Canada NewsWire May 4, 2020

Leading Independent Proxy Advisory Firm ISS Recommends That Correvio Shareholders Vote for the Arrangement with ADVANZ PHARMA

Canada NewsWire May 1, 2020

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Mergers; Are Shareholders Getting a Fair Deal?

PR Newswire April 20, 2020

Correvio Obtains Interim Order For Plan Of Arrangement

Canada NewsWire April 8, 2020

Correvio Reports Full Year 2019 Financial Results

PR Newswire March 30, 2020

Are Shareholders Getting a Fair Deal? Halper Sadeh LLP Investigates the Sale of These Companies - CORV, TERP, IOTS, CBB

GlobeNewswire March 24, 2020
View More News ››

Opinion & Analysis (NDAQ:CORV)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:CORV)

RE:RE:why it is very risky to invest?

This is nearly following William Hunter's playbook with angiotech some years ago: develop a drug product with decent sales, expand...
slithey - April 13, 2020

RE:RE:RE:+50% today!

I wasn't far off, apparently Xydalba was mentioned on ABC News as used in the corona treatment according to people on Stocktwits ...
bigkagan - March 5, 2020

RE:RE:+50% today!

could it be anything to do with the Zevtera drug used against pneumonia? I bet some of these corona patients develop bacterial pneumonia...
bigkagan - March 5, 2020

still holding this stock

using dollar cost averaging for this one and it is going up today with markets crashing,so glta.
coolfooldumbguy - February 24, 2020

Is Correvio Getting Bought By Cipher?

On SEDAR Cipher has posted "Articles of Amalgamation" with Cardiome Corporation which I bleieve was Correvios former name? ...
shareswapper - February 13, 2020

RE:RE:Aww man this was supposed to be my early retirement 🤢

if China approves Brinavess we could go back to $2 easy IMHO, they are not as fussy as FDA which still bans the cyclamate although the...
bigkagan - December 30, 2019
View more Bullboard ››

GMV Minerals Inc

GMV Minerals Inc

GMV Minerals Inc. is an exploration company focused on developing precious metal assets in Arizona. The Company, through its ...
View More »